Hog Scour Suspension 2.5 mcg Suspension is a Health Canada–registered veterinary drug (DIN 00308242) held by Professional Veterinary Laboratories, containing Hyoscyamine Sulfate. Health Canada lists its status as Dormant (status date 02 Oct 2020). Nexara Health has matched 95 registrations of Hyoscyamine Sulfate across 6 other regulated markets.
Health Canada registration
| DIN | 00308242 |
|---|---|
| Brand name | Hog Scour Suspension |
| Active ingredient | Hyoscyamine Sulfate |
| Strength | 2.5 mcg |
| Dosage form | Suspension |
| Route | Oral |
| Company | Professional Veterinary Laboratories |
| Status | Dormant — 02 Oct 2020 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Hyoscyamine Sulfate registered in other markets
95 registrations of the same molecule in 6 national registries outside Canada (first 26 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Iceland | Hyoscine | Parlogis - óskráð lyf | 0,4 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Norway | Hyoscyamine Sulfate ani depottab 0,375 mg | ANI Pharmaceuticals | 100 | Depottablett | Aktiv oppføring | FEST (DMP) |
| Norway | Hyoscyamine Sulfate county line depottab 0,375 mg | County Line Pharmaceuticals | 100 | Depottablett | Aktiv oppføring | FEST (DMP) |
| Norway | Hyoscyamine Sulfate laser depottab 0,375 mg | Laser Pharmaceuticals | 100 | Depottablett | Aktiv oppføring | FEST (DMP) |
| Saudi Arabia | Levsin Tab 0.125mg | — | 0.125 | Inactive | SFDA | |
| South Africa | Hyospasmol Syrup | Pharmacare Limited, Woodmead | 5 mg/5ml | Syr | Down Schedule: S2 to S1 | DoH SEP database |
| South Africa | Pharma-Q Hyoscine Butylbromide Injection 20mg/1ml | Pharma-Q Holdings (Pty) Ltd | 20 mg/ml | Inj | S2 | DoH SEP database |
| South Africa | Scopex | Adcock Ingram Limited | 10 mg | Tab | S1 | DoH SEP database |
| South Africa | Scopex | Adcock Ingram Limited | 20 mg/ml | Inj | S2 | DoH SEP database |
| South Africa | Scopex | Adcock Ingram Limited | 5 mg/5ml | Syr | S1 | DoH SEP database |
| Taiwan | Anwashu Tablets | 優良化學製藥股份有限公司 | 錠劑 | Registered | TFDA | |
| Taiwan | Busacon Tablets 0.125mg | 歐帕生技醫藥股份有限公司 | 錠劑 | Registered | TFDA | |
| Taiwan | Butysco Injection | 大豐製藥股份有限公司 | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Buwecon Tablets 0.125mg "Yung Shin" | 永信藥品工業股份有限公司台中幼獅廠 | 錠劑 | Registered | TFDA | |
| Taiwan | Extractum Scopoliae | Iwaki Seiyaku Co. Ltd. | 原料藥浸膏劑 | 已註銷 | TFDA | |
| Taiwan | Extractum Scopoliae | Iwaki Seiyaku Co. Ltd. | 原料藥浸膏劑 | 已註銷 | TFDA | |
| Taiwan | Extractum Scopoliae | Iwaki Seiyaku Co. Ltd. | 原料藥浸膏劑 | 已註銷 | TFDA | |
| Taiwan | Hyoscyamine Sulfate | Hubei Biocause Heilen Pharmaceutical Co.Ltd. | （粉） | 已註銷 | TFDA | |
| United States | Hyoscyamine ER | Pharma Packaging Solutions, LLC dba Tjopack LLC | Tablet, Extended Release | FDA NDC | ||
| United States | Hyoscyamine ER | Mylan Pharmaceuticals Inc. | Tablet, Extended Release | listed | FDA NDC | |
| United States | hyoscyamine sulfate | Proficient Rx LP | Tablet | FDA NDC | ||
| United States | Hyoscyamine sulfate | Chartwell RX, LLC | Tablet, Orally Disintegrating | listed | FDA NDC | |
| United States | Hyoscyamine sulfate | Chartwell RX, LLC | Tablet | listed | FDA NDC | |
| United States | Hyoscyamine sulfate | Chartwell RX, LLC | Tablet, Extended Release | listed | FDA NDC | |
| United States | Hyoscyamine sulfate | Chartwell RX, LLC | Solution | listed | FDA NDC | |
| United States | Hyoscyamine Sulfate | Patrin Pharma, Inc. | Tablet, Extended Release | listed | FDA NDC |
See every manufacturer of Hyoscyamine Sulfate worldwide →
Regulator price references for Hyoscyamine Sulfate
Published list or reimbursement prices for Hyoscyamine Sulfate presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Iceland | Hyoscine | 0.4mg/1ml | lykjur | 15,912.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Saudi Arabia | Levsin Tab 0.125mg | 0.125mg | 19.40 SAR | public | SFDA | 2026-09-01 | |
| South Africa | Scopex | 10mg | 10 | 37.79 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Hyospasmol Syrup | 5mg/5ml | 100 | 52.51 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Scopex | 5mg/5ml | 100 | 58.28 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Pharma-Q Hyoscine Butylbromide Injection 20mg/1ml | 20mg/1ml | 10 | 61.70 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Scopex | 20mg/1ml | 1 | 70.48 ZAR | single exit price | DoH SEP database | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Hog Scour Suspension (DIN 00308242) marketed in Canada?
No. Health Canada lists DIN 00308242 as Dormant as of 02 Oct 2020.
Who holds the Canadian licence for this product?
Professional Veterinary Laboratories is the company of record in the Health Canada Drug Product Database.
Is Hyoscyamine Sulfate registered outside Canada?
Yes — Nexara Health has matched 95 registrations in 6 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00308242, status date 2020-10-02; national medicine registries: DoH SEP database, FDA NDC, FEST (DMP), Lyfjastofnun lyfjaverdskra, SFDA, TFDA; price sources: DoH SEP database, Lyfjastofnun lyfjaverdskra, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00308242, status date 2020-10-02; national medicine registries: DoH SEP database, FDA NDC, FEST (DMP), Lyfjastofnun lyfjaverdskra, SFDA, TFDA; price sources: DoH SEP database, Lyfjastofnun lyfjaverdskra, SFDA.
Health Canada Drug Product Database (DPD), DIN 00308242, status date 2020-10-02; national medicine registries: DoH SEP database, FDA NDC, FEST (DMP), Lyfjastofnun lyfjaverdskra, SFDA, TFDA; price sources: DoH SEP database, Lyfjastofnun lyfjaverdskra, SFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.